Pfizer has informed that it is sending medicines worth $ 70 million (about 510 million) to India from distribution centers in Europe and Asia apart from the US. In an e-mail sent to the employees of Pfizer India, the CEO of the company has said that they are very concerned about the situation of Corona in India and they are with all the people of India at the time of this crisis. In order to deal with the increasing cases of Corona virus and to ensure availability of vaccine, the Government of India had allowed emergency use of imported foreign vaccine in April 2021 itself. read this also- Corona virus kills! Employment of 7 million people lost in April 2021, unemployment rate increased Pfizer first asked for permission for the vaccine The central government had allowed import of only those vaccines that had received emergency approval from the United States Food and Drug Administration, the European Medicine Agency, the UK Medicine and Healthcare Products Regulatory Agency, the Pharmaceutical and Medical Devices Agency, Japan. The Indian government had also allowed those vaccines, which are listed in the World Health Organization (WHO), to be used as an emergency. Before the introduction of the vaccination program in the country, Pfizer was the only pharmaceutical company that first sought permission to use it. However, the Drug Regulatory Authority of India had prohibited the approval of Pfizer’s Kovid vaccine. Earlier, the Subject Expert Committee refused to recommend permission to the Emergency Use Authority. The Subject Expert Committee had said at that time that Pfizer has not proposed any plan to create security and protective data in the Indian population. This is the specialty of Pfizer vaccine and so is the price abroad On December 5, the US pharmaceutical giant had applied to the EUA for the Kovid vaccine in the country. Subsequently, Pune-based Serum Institute of India (SII) applied for Kovishield on 6 December and Bharat Biotech applied for EUA on 7 December for its covaccine. The results of the clinical trial of the Pfizer-BioNotech vaccine can be said to be largely satisfactory. Its afficacy has been found to be up to 95 percent against all infections. However, no corona vaccine in any country of the world has been found to have 100% affixation. Recently, based on the company’s agreement with the European Union, the price of Corona vaccine has been fixed at $ 23 per dose. read this also- Gold Price Today: Gold price today witnessed a sharp trend throughout the day, before buying, see new prices of 10 grams of gold What will be the cost of the Pfizer-BioNotech vaccine The Pfizer-BioNtech vaccine was previously priced at 12 euros. Later it has increased to 15.5 Euros and the new agreement for the year 2022-2023 is at 19.5 Euros. But, what will be its price in India, information can be told only after consultation with the central government. According to the Center for Disease Control and Prevention, the Pfizer vaccine has to be stored in a slightly cooler place. If it is stored at -158 degrees F, then it can be stored for 6 months. Prior to mixing, this vaccine can be stored in a normal freezer temperature of -13 ° to 5 ° F for two weeks, while it can be preserved for up to 5 days in a normal refrigerator. In general, dry ice is used to keep the Pfizer vaccine more cold while transporting it from a thermal ship. In such vessels, the distributor can keep the vaccine for 30 days.